Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation

The complete form of X-linked congenital stationary night blindness (CSNB) is a rare genetic disease caused by a mutation in the NYX gene. CSNB is associated with the mutations taking place in 17 genes, whilst its CSNB1A form is caused by the mutations in the NYX gene, which were characterized earli...

Full description

Bibliographic Details
Main Authors: M. E. Ivanova, K. V. Gorgisheli, I. V. Zolnikova, D. S. Atarshchikov, D. Barh, Zh. M. Salmasi, L. M. Balashova
Format: Article
Language:Russian
Published: Real Time Ltd 2019-08-01
Series:Российский офтальмологический журнал
Subjects:
nyx
Online Access:https://roj.igb.ru/jour/article/view/304
id doaj-01aeb942b8a8469a9671f5327953e5ec
record_format Article
spelling doaj-01aeb942b8a8469a9671f5327953e5ec2021-07-28T13:01:40ZrusReal Time LtdРоссийский офтальмологический журнал2072-00762587-57602019-08-01123778410.21516/2072-0076-2019-12-3-77-84238Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutationM. E. Ivanova0K. V. Gorgisheli1I. V. Zolnikova2D. S. Atarshchikov3D. Barh4Zh. M. Salmasi5L. M. Balashova6Oftalmic Research and Clinical CenterGenomed Genetic LaboratoryHelmholtz National Medical Research Center of Eye DiseasesCentral Clinical Hospital with Polyclinic, Office of the PresidentCenter for Genomics and Applied Gene Technology, Institute of Integrative Omics and Applied Biotechnology (IIOAB)N.I. Pirogov Russian National Research Medical UniversityNon-profit partnership International Scientific and Practical Center for the Proliferation of TissuesThe complete form of X-linked congenital stationary night blindness (CSNB) is a rare genetic disease caused by a mutation in the NYX gene. CSNB is associated with the mutations taking place in 17 genes, whilst its CSNB1A form is caused by the mutations in the NYX gene, which were characterized earlier, although nothing had been reported so far about the Russian founder principle. The paper analyzes the pathogenetic mechanisms in a family with diagnosed CSNB1A and a new genetically confirmed mutation in the NYX gene in four members of one Russian family. Two brothers of the four siblings (two boys, two girls) with congenital stationary night blindness, diagnosed in early childhood, and high myopia underwent a standard ophthalmic examination, supplemented with OCT, electroretinography and color blind test with tables by Rabkin and Farnsworth test, whereupon they were sent to molecular genetics confirmation of the diagnosis by whole exome sequencing with subsequent Sanger sequencing confirmation of the detected mutation in the proband and proband’s relatives. In members of the family with clinical features of CSNB1A the reading frame shift mutation was genetically confirmed in the NYX gene (c.283delC, p.His95fs, NM_022567.2). This mutation is inherited in X-linked form. This is the first report of a case with a novel and probable founder mutation from Russia associated with CSNB1A. Since the mRNA of a NYX gene consists of only 2696 base pairs, a gene replacement therapy, or CRISPR-based gene editing, or a similar approach may be envisaged for the correction of frameshift in His95fs position.https://roj.igb.ru/jour/article/view/304csnb1anyxcongenital stationary night blindnessgene therapyleucine-rich domain
collection DOAJ
language Russian
format Article
sources DOAJ
author M. E. Ivanova
K. V. Gorgisheli
I. V. Zolnikova
D. S. Atarshchikov
D. Barh
Zh. M. Salmasi
L. M. Balashova
spellingShingle M. E. Ivanova
K. V. Gorgisheli
I. V. Zolnikova
D. S. Atarshchikov
D. Barh
Zh. M. Salmasi
L. M. Balashova
Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
Российский офтальмологический журнал
csnb1a
nyx
congenital stationary night blindness
gene therapy
leucine-rich domain
author_facet M. E. Ivanova
K. V. Gorgisheli
I. V. Zolnikova
D. S. Atarshchikov
D. Barh
Zh. M. Salmasi
L. M. Balashova
author_sort M. E. Ivanova
title Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
title_short Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
title_full Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
title_fullStr Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
title_full_unstemmed Pathogenesis and clinical features of congenital stationary night blindness in case of c.283delC NYX gene mutation
title_sort pathogenesis and clinical features of congenital stationary night blindness in case of c.283delc nyx gene mutation
publisher Real Time Ltd
series Российский офтальмологический журнал
issn 2072-0076
2587-5760
publishDate 2019-08-01
description The complete form of X-linked congenital stationary night blindness (CSNB) is a rare genetic disease caused by a mutation in the NYX gene. CSNB is associated with the mutations taking place in 17 genes, whilst its CSNB1A form is caused by the mutations in the NYX gene, which were characterized earlier, although nothing had been reported so far about the Russian founder principle. The paper analyzes the pathogenetic mechanisms in a family with diagnosed CSNB1A and a new genetically confirmed mutation in the NYX gene in four members of one Russian family. Two brothers of the four siblings (two boys, two girls) with congenital stationary night blindness, diagnosed in early childhood, and high myopia underwent a standard ophthalmic examination, supplemented with OCT, electroretinography and color blind test with tables by Rabkin and Farnsworth test, whereupon they were sent to molecular genetics confirmation of the diagnosis by whole exome sequencing with subsequent Sanger sequencing confirmation of the detected mutation in the proband and proband’s relatives. In members of the family with clinical features of CSNB1A the reading frame shift mutation was genetically confirmed in the NYX gene (c.283delC, p.His95fs, NM_022567.2). This mutation is inherited in X-linked form. This is the first report of a case with a novel and probable founder mutation from Russia associated with CSNB1A. Since the mRNA of a NYX gene consists of only 2696 base pairs, a gene replacement therapy, or CRISPR-based gene editing, or a similar approach may be envisaged for the correction of frameshift in His95fs position.
topic csnb1a
nyx
congenital stationary night blindness
gene therapy
leucine-rich domain
url https://roj.igb.ru/jour/article/view/304
work_keys_str_mv AT meivanova pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
AT kvgorgisheli pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
AT ivzolnikova pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
AT dsatarshchikov pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
AT dbarh pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
AT zhmsalmasi pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
AT lmbalashova pathogenesisandclinicalfeaturesofcongenitalstationarynightblindnessincaseofc283delcnyxgenemutation
_version_ 1721277162814701568